Pure Encapsulations announces expansion of PureHeart initiative

Full-service, personalized, cardiometabolic healthcare platform

May 3, 2014 – Pure Encapsulations, a leading manufacturer of research-based, hypo-allergenic nutritional supplements, announces the expansion of its PureHeart initiative with a new strategic partner and innovative daily packet. The PureHeart initiative aligns Pure Encapsulations’ research-based, cardiometabolic supplements with strategic partners to provide healthcare professionals with a full-service, personalized healthcare platform — Screening + Supplements = Success.*

“We announced our newest PureHeart partner—Boston Heart Diagnostics Corporation—at The Institute for Functional Medicine (IFM) Cardiometabolic conference in Boston,” Joy Devins, Vice President, at Pure Encapsulations, said. “We were proud to have as our guest speaker Michael Dansinger, MD, professor at Tufts University and medical director for Boston Heart Diagnostics, who discussed their proprietary biomarker solutions, including HDL Map and Cholesterol Balance Test, along with the Boston Heart Lifestyle Program.”

Along with the new partnership, the latest addition to the PureHeart line of nutritional supplements is PureHeart Pure Pack, a daily packet featuring a comprehensive blend of vitamins, minerals, CoQ₁₀, antioxidants and essential fatty acids designed to support arterial and overall cardiovascular health.*

“PureHeart Pure Pack also includes a unique polyphenol combination, PhytoCardio,” said Kelly Heim, Ph.D., Nutritional Pharmacologist, at Pure Encapsulations. “This proprietary blend of blueberry and cranberry fruit extracts was developed as part of a comprehensive research program with the Institute of Nutrition and Functional Foods (INAF) based at Université Laval, Quebec, Canada.”

In addition to Pure Encapsulations’ newest partner, Boston Heart Diagnostics Corporation and founding partner Cleveland HeartLab, PureHeart  has expanded to include Bariatric and Oral Systemic specialists, as well as SilverStaff Clinical Laboratories.

“Pure is excited to help lead the personalized medicine movement through innovation, research, education and through the partnerships we have developed with these leading biomarker and genetic testing experts,” Devins said.

*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.

Source: PureHeart